# Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer

> **NCT00027521** · PHASE1 · WITHDRAWN · sponsor: **Ichor Medical Systems Incorporated**

## Conditions studied

- Pancreatic Cancer

## Interventions

- **BIOLOGICAL:** bleomycin sulfate
- **DRUG:** electroporation therapy

## Key facts

- **NCT ID:** NCT00027521
- **Lead sponsor:** Ichor Medical Systems Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2000-12
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Program terminated
- **Last updated:** 2012-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00027521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00027521, "Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00027521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*